Company / R&D per Share
Perspective Therapeutics, Inc. R&D per Share History
FY2013-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.01
FY2022
5-year range
$0.01 / $0.03
FY2018-FY2022
Trend
-72.0%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share has fluctuated over the past 10 years, ranging from $0.01 in FY2022 to $0.03 in FY2020.
Based on SEC 10-K filings.
0.01 in FY2022 with a 5-year CAGR of -11.7%.
Declined from $0.03 to $0.01 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -29.6%
- 5-Year CAGR
- -11.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, r&d per share decreased 72.0% year-over-year.
- Peak r&d per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 5.43 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $0.01 | -72.0% |
| FY2021 | $0.02 | -17.4% |
| FY2020 | $0.03 | +51.2% |
| FY2019 | $0.02 | +78.5% |
| FY2018 | $0.01 | -14.2% |
| FY2017 | $0.01 | -30.6% |
| FY2016 | $0.02 | +6.6% |
| FY2015 | $0.02 | -16.7% |
| FY2014 | $0.02 | -28.2% |
| FY2013 | $0.03 | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026